![](/img/cover-not-exists.png)
Partial response or better at six months is prognostic of superior progressionâfree survival in Waldenström macroglobulinaemia patients treated with ibrutinib
Castillo, Jorge J., Abeykoon, Jithma P., Gustine, Joshua N., Zanwar, Saurabh, Mein, Kirsten, Flynn, Catherine A., Demos, Maria G., Guerrera, Maria L., Kofides, Amanda, Liu, Xia, Munshi, Manit, TsakmakJournal:
British Journal of Haematology
DOI:
10.1111/bjh.17225
Date:
November, 2020
File:
PDF, 779 KB
2020